Brain State Technologies (Scottsdale, Arizona) is pleased to announce success in providing significant symptom reduction of persisting post-concussion symptoms (PPCS) resulting from use of their HIRREM technology, according to their latest research findings.
This year, the researchers are presenting results from nineteen athletes, including new data showing that symptom reductions were maintained when the athletes were evaluated at a later follow-up visit. Of significant note for professional athletes; there were also durable improvements in reaction time, which is shown to be slowed after concussion, and improvements in variability of their heart rates, suggesting greater capacity for the heart to make rapid, adaptive changes in its pumping function. At the Inaugural Sports Concussion Conference in 2014, the Wake Forest-Brain State research team presented data from twelve young athletes with PPCS, who had significant reduction in concussion symptoms after completing a series of HIRREM sessions. Ten of those athletes were able to return to full participation in their competitive sports, as a result.
Concussion can result in debilitating symptoms including headache, sleep disturbance, nausea, cognitive difficulties, and depression. While most athletes recover within a few days, roughly ten percent go on to have symptoms that last longer. Not only are these types of injuries and their related symptoms potentially career ending for professional athletes, but they may be severe enough to affect their personal lives as well. Concern about the symptoms and potential long-term effects of athletic concussion has increased in recent years, with recognition of chronic traumatic encephalopathy (CTE) in athletes exposed to repeated head impacts, including National Football League (NFL) players. Few scientific studies suggest that current treatment options are effective in helping athletes with persisting post-concussion symptoms (PPCS), to reduce their symptoms sufficiently so that they can return to their professional careers. Based on the success of HIRREM technology in PPCS, it would make sense to expand its availability to more athletes who would benefit from PPCS symptom relief; providing the potential to successfully continue with their careers.
The results were presented at the Third Annual Sports Concussion Conference of the American Academy of Neurology, July 8-10, in Chicago, Illinois, in conjunction with a research team based at Wake Forest School of Medicine (Winston-Salem, North Carolina). Brain State Technologies is presenting data from a series of young athletes with persisting post-concussion symptoms (PPCS), who received a series of HIRREM® sessions as part of a larger exploratory clinical study that has been ongoing at Wake Forest since 2012.
Developed by Brain State Technologies’ Founder & CEO, Lee Gerdes, in 2004 as self-treatment for PTSD and mTBI, HIRREM is a noninvasive computer-based technology that supports the brain to self-adjust its electrical activity patterns. It works through software algorithms that translate brainwave frequencies into sound frequencies – audible tones – in real time, that the user listens to through ear buds, allowing the brain to hear its own patterns and begin to self-adjust; becoming more balanced. In other clinical studies, HIRREM has produced greater balance in brain electrical activity, resulting in improved sleep, reduction in symptoms from post-traumatic stress disorder (PTSD), traumatic brain injury (TBI), and other benefits.
The study was supported by a research grant from the not-for-profit Susanne Marcus Collins Foundation, Inc., to the Department of Neurology at Wake Forest School of Medicine. More information about HIRREM technology is available from Brain State Technologies, telephone (480)588-6840. For more information about clinical studies of HIRREM, visit www.wakehealth.edu/hirrem.
HIRREM is the core technology behind Brainwave Optimization, but is for different intended uses.